Mandate

Vinge advises founder and major shareholders on the sale of Dynamic Code AB

September 17, 2021 M&A

Vinge is advising the founder and major shareholders in connection with the sale of Dynamic Code AB.

Dynamic Code develops and sells self-sampling kits based on DNA technology. The samples are analysed in Dynamic Code’s own lab and the test results are obtained through a code online. Care and treatment is thereafter offered via digital health care providers and Dynamic Code has, based on that, been able to create a complete chain of health care through its e-health platform.

Closing of the transaction is subject to due diligence and that shareholders representing 95 per cent of all shares in Dynamic Code adhere to the share transfer agreement.

The Vinge team includes Anna Edström, Magnus Hedsund and Niklas Törnell.

 

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025